Life ScienceCompany
Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection Ownership
Who owns Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection?
Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is owned by Teligent. It was acquired on October 5, 2015.
Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection Business Overview
Where is Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection headquartered?
Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is headquartered in Oakville, Ontario.
What sector is Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection in?
Concordia Pharmaceuticals - Frotaz Zinacef ad Zantac Injection is a life science company.
Life Science M&A Summary in 2015
Out of 60 sectors in the Mergr database, life science ranked 7 in number of deals in 2015. The largest life science acquisition in 2015 was Allergan - which was acquired by Allergan for $70.5B.
Join Mergr to view all 293 acquisitions of life science companies in 2015, including 32 acquisitions by private equity firms, and 261 by strategics.